Lee CY(李雋元), Lin YP, Lin CY, Chen TC, Kuo SH, Lo SH, Wang SF, Po-Liang Lu(盧柏樑)

Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020. J Infect Public Health. 2024 Feb (SCIE, IF=6.7, PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Rank=28/207, 13.5%)

Lu MY, Huang CF(黃釧峰), Hung CH, Tai CM, Mo LR, Kuo HT, Tseng KC, Lo CC, Bair MJ, Wang SJ, Huang JF(黃志富), Yeh ML(葉明倫), Chen CT, Tsai MC, Huang CW, Lee PL, Yang TH, Huang YH, Chong LW, Chen CL, Yang CC, Yang SS, Cheng PN, Hsieh TY, Hu JT, Wu WC, Cheng CY, Chen GY, Zhou GX, Tsai WL, Kao CN, Lin CL, Wang CC, Lin TY, Lin CL, Su WW, Lee TH, Chang TS, Liu CJ, Chia-Yen Dai(戴嘉言), Kao JH, Lin HC, Chuang WL(莊萬龍), Peng CY, Tsai CW, Chen CY,  Yu ML(余明隆)*; TACR Study Group.

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.Clin Mol Hepatol. 2024 Jan (SCIE, IF= 14, GASTROENTEROLOGY & HEPATOLOGY Rank: 6/143=4.2%)

Yu ML(余明隆), Tai CM, Mo LR, Kuo HT, Huang CF(黃釧峰), Tseng KC, Lo CC, Bair MJ, Wang SJ, Huang JF(黃志富), Yeh ML(葉明倫), Chen CT, Tsai MC, Huang CW, Lee PL, Yang TH, Huang YH, Chong LW, Chen CL, Yang CC, Hung CH, Yang SS, Cheng PN, Hsieh TY, Hu JT, Wu WC, Cheng CY, Chen GY, Zhou GX, Tsai WL, Kao CN, Lin CL, Wang CC, Lin TY, Lin CL, Su WW, Lee TH, Chang TS, Liu CJ, Chia-Yen Dai(戴嘉言), Chen CY, Kao JH, Lin HC, Chuang WL(莊萬龍), Peng CY.

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan. Hepatol Int. 2024 Jan (SCIE,IF=6.6 GASTROENTEROLOGY & HEPATOLOGY, Rank=21/93(22.6%))

Lin HH, Li JW, Yang TY, Lee CY(李雋元), Jain SH, Lin SY, Po-Liang Lu(盧柏樑)*.

Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021. J Microbiol Immunol Infect. 2023 Aug 56(4):833-841. (SCIE, IF=7.4 MICROBIOLOGY Rank=20/135, 14.8%)

Tsai PC, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML(葉明倫), Huang CF(黃釧峰), Hsieh MH, Huang JF(黃志富), Dai CY(戴嘉言), Chung WL(莊萬龍), Chen CY, Yu ML(余明隆)*; T-COACH Study Group.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan. JOURNAL OF HEPATOLOGY.Epub 2022 Oct 5. (SCIE, IF=30.083 GASTROENTEROLOGY & HEPATOLOGY, Rank = 5/93(5.38%))

Huang CF(黃釧峰), Tseng KC, Cheng PN, Hung CH, Lo CC, Peng CY, Bair MJ, Yeh ML(葉明倫), Chen CH, Lee PL, Lin CY, Kuo HT, Chen CT, Yang CC, Huang JF, Tai CM, Hu JT, Lin CL, Su WW, Tsai WL, Huang YH, Cheng CY, Lin CL, Wang CC, Yang SS, Mo LR, Chen GY, Chang CC, Wang SJ, Huang CS, Hsieh TY, Lin CW, Lee TH, Chong LW, Huang CW, Chang SN, Tsai MC, Hsu SJ, Kao JH, Liu CJ, Liu CH, Lin HC, Lee MH, Tsai PC, Dai CY, Chuang WL(莊萬龍), Chen CY, Yu ML(余明隆)*. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR). Clinical Gastroenterology and Hepatology. 2022 May;20(5):1151-1162.e6. (SCIE, IF = 13.576 GASTROENTEROLOGY & HEPATOLOGY, Rank = 7/93 (7.53%))

Tsai YS, Huang CI, Tsai PC, Yeh ML, Huang CF(黃釧峰), Hsieh MH, Liu TW, Lin YH, Liang PC, Lin ZY, Chen SC, Huang JF(黃志富), Chuang WL(莊萬龍), Dai CY(戴嘉言), Yu ML(余明隆)*.

Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients. Cancers (Basel).

2022 Apr 16;14(8):2023. (SCIE, IF = 6.575 ONCOLOGY, Rank = 60/245 (24.49%))

Hsu PY, Liang PC, Chang WT, Lu MY, Wang WH, Chuang SC, Wei YJ, Jang TY, Yeh ML(葉明倫), Huang CI, Lin YH, Wang CW, Hsieh MY, Hou NJ, Hsieh MH, Tsai YS, Ko YM, Lin CC(林敬智), Chen KY,Dai CY(戴嘉言), Lin ZY, Chen SC, Chung WL(莊萬龍), Huang CF(黃釧峰), Huang JF(黃志富), Yu ML(余明隆)* Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma. 2022 Dec 15;12(12):5576-5588. (SCIE, IF=5.942 ONCOLOGY, Rank = 71/245(28.98%))

Wang HW, Tsai PC, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Su WW, Chu CH, Chen CJ, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Huang JF(黃志富), Dai CY(戴嘉言), Chung WL(莊萬龍), Yu ML(余明隆)* Peng CY. Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study. American Journal of Cancer Research 2022 Jul 15;12(7):3164-3174. (SCIE, IF=5.942 ONCOLOGY,   Rank = 71/245(28.98%))

Tai CM, Huang CK, Changchien TC, Lin PC, Wang DW, Chang TT, Chan HW, Chen TH, Tseng CH, Chen CC, Tsai CT, Sie YT, Yen YC, Yu ML(余明隆)*. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.Viruses.2022 Jul 27;14(8):1637.   (SCIE, IF=5.818 VIROLOGY, Rank = 14/37       (37.84%))

Chan LP (曾良鵬), Tseng YP, Wang HC, Chien CY, Wu CW, Wang LF, Liang CH.

Growth regulated oncogene-α contribute to EMT/MMPs pathway by binding its receptors in head and neck squamous cell carcinoma.  LIFE SCIENCES    2022 Oct 1;306:12079    (SCIE, IF = 6.780   Pharmacology & Pharmacy, Rank = 36/279(12.90%))

Ke HL, Li CC, Lee HY, Tu HP, Wei YC, Yeh HC(葉信志), Wu WJ(吳文正), Li WM*(李威明). Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.    Cancers (Basel). 2022 Mar12;14(6):1466. (SCIE, IF = 6.575 ONCOLOGY, Rank = 60/245(24.49%))

F Ou-Yang , CL Li , CC Chen, YC Shen, SH Moi, CW Luo(羅啟文), WY Xia, YN Wang, HH Lee, LH Wang, SC Wang, MR Pan, MF Hou*(侯明峰), MC Hung.

De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patients. American Journal of Cancer Research 2022; 12(1):123-137 (SCIE, IF=5.942        ONCOLOGY, Rank = 71/245 (28.98%))

Ke HL, Li CC, Lee HY, Tu HP, Wei YC, Yeh HC(葉信志), Wu WJ(吳文正), Li WM*(李威明). Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.Cancers (Basel).2022 Mar12;14(6):1466. (SCIE,     IF = 6.575 ONCOLOGY, Rank = 60/245      (24.49%))

Yeh HC(葉信志), Chang CH, Fang JK, Chen IA, Lin JT, Hong JH, Huang CY, Wang SS, Chen CS, Lo CW, Yu CC, Tseng JS, Lin WR, Jou YC, Cheong IS, Jiang YH, Tsai CY, Hsueh TY, Chen YT, Huang HC, Tsai YC, Lin WY, Wu CC, Lin PH, Lin TW, Wu WJ.

The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study."    Frontiers in Oncology 2022 Jun 2;12:872849.       (SCIE, IF = 5.783 ONCOLOGY, Rank = 78/245(31.84%))

Chun-Yuan Lee(李雋元), Yi-Pei Lin, Sheng-Fan Wang, Po-Liang Lu(盧柏樑)*.

Late cART Initiation Consistently Driven by Late HIV Presentation: A Multicenter Retrospective Cohort Study in Taiwan from 2009 to 2019." Infectious Diseases and Therapy 2022 Mar 18. (SCIE, IF = 6.119 INFECTIOUS DISEASES, Rank=26/95 (27.37%))

Huang LC, Chen MH, Chuu CP, Li KY, Hour TC, Yang YH*(楊淵韓).

Plasma biomarkers and their correlation in adult children of parents with Alzheimer's disease. Frontiers in Aging Neuroscience 2022 Aug 30;14:977515. (SCIE, IF=5.702 NEUROSCIENCES, Rank=67/275    (24.36%))

Huang LC, Chen MH, Chuu CP, Li KY, Hour TC, Yang YH*(楊淵韓). Plasma biomarkers and their correlation in adult children of parents with Alzheimer's disease.Frontiers in Aging Neuroscience 2022 Aug 30;14:977515. (SCIE, IF=5.702 NEUROSCIENCES,Rank=67/275 (24.36%))

Wu CC, Wang CC, Chung WY, Sheu CC, Yang YH, Cheng MY, Lai RS, Leung SY, Lin CC, Wei YF, Lin CH, Lin SH, Hsu JY, Huang WC, Tseng CC, Lai YF, Cheng MH, Chen HC, Yang CJ, Hsu SC, Su CH, Wang CJ, Liu HJ, Chen HL, Hsu YT, Hung CH*(洪志興), Lee CL, Huang MS, Huang SK. Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study".     Thorax 2023 Mar;78(3):225-232.  (SCIE, IF=9.203 RESPIRATORY SYSTEM, Rank=9/66(13.63%))

Wu DW, Cheng YC, Wang CW, Hung CH(洪志興), Chen PS, Chu-Sung Hu S, Richard Lin CH, Chen SC*(陳思嘉), Kuo CH. Impact of the synergistic effect of pneumonia and air pollutants on newly diagnosed pulmonary tuberculosis in southern Taiwan". ENVIRONMENTAL RESEARCH  2022 Sep;212(Pt B):113215(SCIE, IF=8.431 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH, Rank=21/210(10.00%))